We report the cloning of a cDNA encoding a Xenopus laevis Ets-type transcription factor. This new Xenopus gene belongs to the PEA3 subfamily of Ets proteins and shows the highest degree of sequence similarity to the mouse and human ER81 genes. The Xenopus ER81 gene (XER81) is transcribed in the embryo after mid blastula transition (MBT) and three transcripts of 3, 4 and 6 kb are detected throughout embryogenesis. XER81 mRNA is localized in the animal pole of the late blastula stage and higher levels of XER81 transcripts are detected in the marginal zone at the onset of gastrulation. In later embryogenesis XER81 transcripts are found in neural crest cells, eyes, otic vesicles and pronephros. The transcription of XER81 can be stimulated by bFGF and eFGF in animal and vegetal cap explants. Expression of the dominant negative FGF receptor mutant in animal caps and embryos blocks XER81 transcription, arguing that the expression of this Ets gene requires active FGF signaling. The spatial overlap of eFGF and XER81 expression domains supports the idea that XER81 transcription could be a marker for regions with active FGF signaling in the embryo.
Introduction
The mesoderm in Xenopus embryos forms in an equatorial region, the marginal zone, located between the animal and the vegetal pole. The exact mechanism by which this part of the embryo acquires mesodermal identity in vivo is not yet known. It is thought, however, that growth factors of the TGF-b and FGF families play an important role in mesoderm induction. eFGF is expressed in the marginal zone at gastrula stages and is therefore a component of the mesodermal program in Xenopus (Isaacs et al., 1995) . Dominant-negative versions of the FGF and activin type II receptors suppress mesoderm formation (Amaya et al., 1991; Hemmati-Brivanlou and Melton, 1992) . When zygotic transcription starts in the embryo after the midblastula stage, the marginal zone expresses a defined set of genes which presumably play a role in mesoderm specification and patterning. In the dorsal marginal zone, organizer specific genes are activated, and around the same time, genes that can antagonize the Spemann organizer are expressed in the ventral marginal zone. These antagonistic activities are responsible for the dorsal-ventral patterning of the mesodermal tissue, which results in the formation of dorsal mesoderm derivatives such as notochord and muscle as well as ventral mesoderm components such as pronephros and blood.
In contrast to the genes that are expressed in defined dorsal or ventral regions of the marginal zone, another set of genes is active throughout the entire prospective mesoderm. These genes display ring shaped expression domains and are very likely involved in establishing mesodermal identity. Examples for such mesoderm specific genes are the T-box transcription factors such as Xbra (Smith et al., 1991) , as well as the caudal genes (Pillemer et al., 1998) . Expression of dominant-negative receptor mutants for FGF and activin interferes with the transcription of Xbra and Xcad-2 and demonstrates that growth factor signaling is required to activate these genes in the marginal zone (Amaya et al., 1993; Pillemer et al., 1998) .
In order to find yet unidentified genes expressed in the prospective mesoderm at gastrula stages, we performed a whole-mount in situ screening procedure on early Xenopus embryos. Random clones from a plasmid cDNA library derived from ventral halves of Xenopus gastrulae were tested for expression in gastrula, neurula and tailbud stages. One of the isolated cDNAs encodes a novel Xenopus Etstype transcription factor, XER81. The family of Ets transcription factors is involved in normal development and cell differentiation and deregulation of their activity often leads to tumorigenesis (for review see Sharrocks et al., 1997) . The ETS-domain which contains the DNA binding motif is highly conserved among the more than 40 known family members isolated from a variety of metazoan species. Ets proteins bind as monomers to the core sequence GGAA/T and belong to the winged helix-turnhelix superfamily of transcription factors (Donaldson et al., 1994) . Ets-related proteins have been shown to act as transcriptional activators or repressors (for review see Sharrocks et al., 1997) . Ets proteins are divided into subgroups by sequence similarity based on the ETS-domain or additional sequence motifs. One subfamily of the Ets proteins, the PEA3 group, consists of three members: PEA3 (Xin et al., 1992; Higashino et al., 1993) , ERM (Chotteau-Lelievre et al., 1997; Monte et al., 1994) and ER81 (Brown and McKnight, 1992; Jeon et al., 1995; Monte et al., 1995) in mice and humans.
Little is known about their functional roles, but all of them seem to be involved in carcinogenesis. In Ewing's sarcoma tumors, PEA3 and ER81 are fused to the RNAbinding protein gene EWS (Jeon et al., 1995; Urano et al., 1996) and human breast cancer cells express all three members of the PEA3 group. In this type of tumor, PEA3 has been shown to transactivate the promoters of types I and IV collagenase . In addition, Ras dependent MAP kinase activity has been shown to activate the PEA3 group proteins by phosphorylation (Janknecht, 1996; Janknecht et al., 1996; O'Hagan et al., 1996) . Little is known about the transcriptional regulation of the PEA3 group in normal and cancer cell systems.
In this study we report the cloning of the Xenopus ER81 cDNA, analyze the expression pattern during embryonic development and present evidence that the transcriptional activation of this gene requires FGF signaling.
Results

XER81 cDNA encodes a putative protein with an Ets DNA-binding domain
In order to find new genes that are expressed in the mesoderm, we performed a whole-mount in situ hybridization screening procedure. A plasmid cDNA library was generated from ventral halves of Xenopus gastrulae (stages 10-12). Digoxigenin-labeled antisense RNAs were synthesized from randomly picked clones and whole-mount in situ hybridizations were performed on gastrula, neurula and tailbud stage embryos (for details see Section 4). Using this strategy, we were able to detect several mRNAs that were preferentially expressed in the marginal zone of gastrula-stage embryos. One of the cDNAs was chosen for further characterization. The deduced amino acid sequence showed high sequence similarity to the human and mouse Ets-related proteins ER81 (Brown and McKnight, 1992; Monte et al., 1995) . This 2800 bp clone pSER81 contained part of the coding region and about 1600 bp of 3′ untranslated sequences. In order to obtain the fulllength XER81 cDNA a lambda-ZAP library of stage 18 Xenopus embryos (Stratagene) was screened with a 600 bp fragment from the 5′ end of the original clone located within the coding region (nt 340-949). Four clones were isolated and sequenced and three of them contained the complete ER81 coding region (Fig. 1A) . The open reading frame encoded an ETS binding domain (nt 1086-1343) whose predicted amino acid sequence is identical to the corresponding domains in mouse and human ER81 proteins. Outside the ETS domain, which is crucial for DNA-binding (Karim et al., 1990) , the degree of amino acid identity between Xenopus, mouse and human ER81 is 83%. ER81 belongs to the PEA3 subfamily of Ets proteins which comprises a 32 amino acid acidic domain located at the N-terminus (nt 219-314) in addition to the highly conserved ETS domain. XER81 also exhibits a high degree of identity both within and without the ETS domain with mouse and human ERM and PEA3 (Fig. 1B ). In contrast, the three published Ets proteins Xenopus Ets-1, -2 and Xfli Wolff et al., 1990; Meyer et al., 1993) lack the N-terminal acidic domain and show only 63% identity to XER81 within and 9% outside the ETS domain. These sequence comparisons demonstrate that the isolated cDNA is the Xenopus homologue of the Ets transcription factor ER81.
Expression of XER81 during normal development
Northern blotting was used to analyze the temporal expression of XER81 during early Xenopus development. Three mRNA species with lengths of 3, 4 and 6 kb were found using a 32 P-labeled fragment corresponding to nucleotides 340-2958 as a probe (Fig. 2) . The same set of transcripts was detected with an ER81-specific probe. This DNA fragment spans the region between the acidic domain and the ETS domain (nt 340-949) which is most divergent within the members of the PEA3 group in mice and humans (Chotteau-Lelievre et al., 1997) . From this result, we conclude that the 3, 4 and 6 kb transcripts are specific for ER81 and not due to cross-hybridization to other members of the PEA3 group. It remains to be elucidated whether the different XER81 mRNAs represent splice variants or can be attributed to alternative promoter usage. Another explanation would be the presence of two closely related genes due to the pseudotetraploidy of Xenopus laevis.
All three transcripts are maternally expressed, with the 3 kb transcript being the most abundant maternal component (egg and stage 6). Reduced levels were detected during gastrulation, neurulation and in tailbud embryos (stage 10-33). The 4 and 6 kb transcripts showed a similar timecourse of expression with the difference that a significant increase in expression levels was detected between gastrula and neurula stages. To test whether distinct mRNA sizes can be correlated with specific germ layers we performed Northern blot analysis on embryo fragments. Animal cap regions (ectoderm) and marginal zones (mesoderm) were isolated from gastrula embryos and the distribution of the 3, 4 and 6 kb transcripts was compared to whole embryos of the same developmental stage. When mesoderm was induced in animal caps by FGF the levels of all three transcripts were elevated, supporting the notion that none of the three transcripts was germ layer-specific (data not shown). Our Northern blot analysis shows that XER81 mRNAs are supplied maternally and that zygotic expression peaks at neurula stages.
In order to analyze the spatial expression pattern of XER81 we performed whole-mount in situ hybridization on Xenopus embryos at different developmental stages. At the late blastula stage, XER81 mRNA was found in the animal region. At the onset of gastrulation, the dorsal marginal zone displayed elevated levels of transcripts. As gastrulation proceeded, the intensity of the XER81-specific signal decreased in the animal cap and became stronger in the marginal zone, the prospective mesoderm ( Fig. 3A-C) . At neurula stages, the expression pattern-became more complex. Two main domains of XER81 expression could be discriminated in a stage 18 embryo. In the anterior domain, distinct portions of the fore-, mid-and hindbrain as well as mesodermal and neural crest derivatives expressed the gene. The posterior expression domain included the prospective tailbud region and caudal neural crest cells (Fig. 3D ). During tailbud stages XER81 was expressed in parts of the fore-, mid-and hindbrain, the otic vesicles, the eyes, the branchial arches and the heart anlage. In addition to the tailbud region, strong signals were seen in the pronephros (Fig. 3E,F) . Histological analysis confirmed that XER81 is expressed during embryogenesis in mesodermal and ectodermal derivatives (data not shown).
In order to resolve the highly dynamic expression pattern of XER81 during gastrulation, we used 100 mm thick vibratome sections of embryos at stages 10-12 for the in situ hybridization procedure (Fig. 4) . In all gastrula stages analyzed the animal cap region expressed XER81. At stage 10+ the level of zygotic XER81 transcripts rose in the dorsal marginal zone above the blastopore lip. In the process of gastrulation, the expression domain in the marginal zone expanded towards the ventral side. Between stages 10.5 and 12, transcript levels in the ventral marginal zone increased in intensity but remained constant on the dorsal side ( Fig. 4C-F) .
The in situ analysis revealed a temporal sequence of 
XER81 expression is dependent on FGF signaling
The expression of XER81 in the marginal zone at gastrula stages suggested a connection of this gene with the forming mesoderm. We therefore asked whether the transcription of XER81 could be induced by mesoderm-inducing growth factors (MIFs). To address this question, animal caps of blastula embryos were dissected and cultured in the presence or absence of MIFs. In the absence of mesoderminducing growth factors, animal caps differentiate into atypical epidermis and in the presence of bFGF or Activin protein, members of the TGF-b family, mesodermal tissues are induced in such explants. This mesoderm induction process can be assayed by the analysis of marker genes at various stages of development. In animal caps that were explanted at stage 8.5 and cultured until stage 15 without growth factors no XER81 transcripts could be detected in an RT-PCR assay. Xbra, a panmesodermal marker, was also not expressed indicating that no mesoderm was induced. The absence of XER81 transcripts in stage 15 animal cap explants indicated that at this time point the maternal messages had disappeared and that no zygotic transcripts were induced in this tissue. Both bFGF and activin protein induced the expression of XER81 and Xbra in the animal cap assay (Fig. 5A ,B) concomitant with the induction of mesoderm. The formation of mesodermal tissue requires a functional FGF signaling pathway. The vegetal hemisphere of the Xenopus blastula is a region in which FGF signaling is Fig. 2 . XER81 is expressed maternally and zygotically and expresses three messages. Embryos were harvested at the indicated developmental stage (NF, Nieuwkoop and Faber, 1967) , and 1.5 embryo equivalents total RNA were used for Northern blotting. Histone H4 mRNA was used as a loading control. Three XER81-specific transcripts of 3, 4 and 6 kb are detectable. The 3 kb transcript is strongest in pre-MBT stages (egg and stage 6). Expression of the 4 and 6 kb transcripts peaks at neurula stages (stages 13-23). limited because it contains low levels of bFGF protein and FGF receptor (Song and Slack, 1994; Cornell et al., 1995) . We therefore asked whether the stimulation of the FGF pathway in vegetal cap explants could induce XER81 transcription (Fig. 5C,D) . Vegetal caps explanted at stage 9 and cultured until stage 11 displayed very low levels of XER81 and no Xbra transcripts. Overexpression of the wild type FGF receptor did not stimulate XER81 transcription and did not induce Xbra expression. When, however, eFGF was overexpressed in the explants, XER81 transcription was stimulated and Xbra was induced. The induction of both genes was even more dramatic when both eFGF and the FGF receptor were ectopically expressed in the vegetal caps. These results show that TGF-b signaling that is supposed to be active in the vegetal hemisphere is not sufficient to induce XER81. In contrast, FGF signaling is sufficient to induce XER81 transcription in animal cap explants where TGF-b signaling is absent. The stimulation of XER81 transcription on animal caps treated with activin could be due to the high dose of the growth factor used in this experiment. The endogenous TGF-b growth factor concentration could not be high enough to induce XER81 in vegetal caps. An alternative scenario however could be that activin stimulates Xbra in animal caps which in turn induces eFGF. Therefore the stimulation of XER81 by activin would be mediated by FGF. These data together with the enhanced XER81 expression in the marginal zone argue that the zygotic transcription of this gene is dependent on a functional FGF signaling pathway.
To test this hypothesis, we asked whether expression of the dominant negative FGF receptor could block the transcriptional activation of XER81. Synthetic mRNA coding for the dominant negative FGF receptor (XFD) was injected into the equatorial region of 4 cell embryos and the expression of XER81 was analyzed by whole-mount in situ hybridization (Fig. 6 ). Ectopic XFD expression dramatically reduced XER81 staining in the marginal zone indicating that blocking of the FGF pathway inhibited XER81 transcription. A similar repression of other mesodermal genes such as Xbra, Xombi and Xcad-3 by XFD was obtained (Amaya et al., 1993; Northrop and Kimelman, 1994; Lustig et al., 1996) . In animal cap explants expressing XFD, FGF protein was unable to induce XER81 and Xbra transcription. This blockade could be released by overexpression of the wild type FGF receptor (Fig. 6) . The experiments described above indicate that FGF signaling is sufficient and necessary for the activation of XER81 transcription. XER81 seems, therefore, to be a downstream component of the FGF-dependent cascade that is involved in patterning the mesoderm.
Overexpression of XER81 does not alter the expression of early mesodermal markers
In order to obtain information about the role of XER81 in vivo, we asked whether overexpression of this gene has an influence on axis formation and mesodermal patterning. For the injection experiments, the coding region of the XER81 gene was cloned into the CS2+ vector that contained six copies of the myc tag epitope (CMT). This construct was either injected as supercoiled plasmid DNA or synthetic XER81 mRNA transcribed in vitro from this clone. The myc-tagged version of the XER81 protein can be detected by the monoclonal antibody 9E10 which allowed us to test the efficiency of protein expression after injection of the plasmid or of the synthetic mRNA in the embryo. Western blot analysis of embryos at stage 10.5 demonstrated that, after injection of synthetic XER81 mRNA or DNA, a single myc-tagged protein with the expected size of 71 kDa was present in the embryo (Fig. 7A) . When embryos were injected with the XER81myc mRNA or DNA at the 8 cell stage and stained with the 9E10 antibody at early gastrula stages, XER81 protein was preferentially found in the nuclei, as expected due to the fact that Ets related proteins are transcription factors. In cells that contained high amounts of XER81 protein, cytoplasmic staining was detectable in addition to the strong nuclear signal (Fig. 7B) . Furthermore, the XER81myc fusion protein was able to bind in vitro to an oligonucleotide (E74) that contained a binding site for Ets proteins (data not shown). These experiments demonstrate that after injection of synthetic CMT-XER81 mRNA or CMT-XER81 DNA, a protein of the expected size was synthesized, which was able to enter the nucleus and to bind to DNA at specific ETS binding sites.
Based on these results we investigated on the effects of overexpression of XER81 in the developing embryo. The interaction of XER81 and the ETS binding domain should modulate the transcription of target genes. Because XER81 is strongly expressed in the forming mesoderm, it could be a transcriptional regulator of the genes expressed in this region. We therefore tested this assumption by injecting synthetic XER81 transcripts into the equatorial region of 4-cell embryos and analyzed the expression of Xbra and Xcad-2 by whole-mount in situ hybridization. In case XER81 is negatively or positively regulating the transcription of these genes we should be able to observe an altered expression pattern in the XER81 injected embryos. Injection of 200 pg-2 ng XER81 mRNA per embryo did not change the expression pattern of Xbra or Xcad-2 transcripts in embryos of stage 10.5-11. The intensity of Xbra staining in the marginal zone was the same in uninjected (Fig. 7Ca ) and XER81 injected (Fig. 7Cb) embryos. The same held true for Xcad-2 expression (Fig. 7Cc,d) , where the dorsal lip in uninjected and injected embryos showed weaker staining than the ventrolateral mesoderm.
The zygotic expression of XER81 in the marginal zone is very dynamic. It starts in the dorsal marginal zone and then expands to the ventrolateral region. Toward the end of gastrulation, XER81 expression on the ventral side is stronger than in the dorsal marginal region. Injection of synthetic XER81 mRNA alters this expression pattern because overexpressed protein is present in the marginal zone several hours earlier than the endogeneous product. Xbra and Xcad-2 also display a strict temporally controlled expression in the marginal zone. Xbra transcription starts dorsally and expands to a ring as gastrulation proceeds. In contrast to XER81 and Xbra the dorsal marginal zone only weakly expresses Xcad-2. We therefore tested the effect of XER81 overexpression on the temporal expression pattern of Xbra and Xcad-2 during gastrulation. As in uninjected samples, Xbra expression starts in the dorsal marginal zone and expands ventrally in embryos overexpressing XER81 at the same stage of development (data not shown). The gap in Xcad-2 transcription in the dorsal marginal zone was unaffected by the ectopic expression of XER81 (data not shown). The transcription of other genes expressed in the marginal zone such as eomesodermin, Xcad-1 and Xcad-3 was also not altered by overexpression of XER81 (data not shown).
This finding implies that XER81 is downstream or regulated independently from these factors. The previously described experiments, which demonstrate that XER81 transcription requires FGF signaling, connect this gene to the process of mesoderm specification. The finding that the expression of early mesodermal marker genes such as Xbra and Xcad-2 was not affected after overexpression argues against a strong effect of XER81 on dorsal-ventral patterning of the mesoderm or anterior-posterior axis formation. This notion is supported by the analysis of XER81 expression in embryos in which the dorsal-ventral polarity of the mesoderm was perturbed. In LiCl treated embryos the formation of dorsal mesoderm is enhanced, whereas in UV irradiated embryos, only ventral mesoderm can be found. The dorsalization or ventralization of mesoderm is reflected by dramatic changes in the expression of dorsal and ventral marker genes. The expression pattern of XER81 and the signal intensity in whole-mount in situ hybridizations were unchanged in LiCl or UV-treated embryos compared to the untreated controls (data not shown).
From these experiments we conclude that XER81 is more likely to be involved in giving the marginal zone a mesodermal identity than in dorsal-ventral patterning of the marginal zone.
Discussion
Ets genes in development
In many organisms transcription factors of the Ets super-family are involved in the regulation of developmental processes through the activation or repression of the target genes (for review see Sharrocks et al., 1997) . The Drosophila gene pointed (Ets-2) acts as a transcriptional activator and is crucial for the formation of the fly eye (Brunner et al., 1994) . Another component involved in Drosophila eye development, the Ets protein YAN, acts as a transcriptional repressor and inhibits cellular differentiation (O'Neill et al., 1994) . A similar function has been described for the C. elegans Ets transcription factor lin-1 (Beitel et al., 1995) . In Xenopus, three Ets genes are known: Xfli, X-ets-1 and Xets-2 and these three proteins act as transcriptional activators Wolff et al., 1990; Meyer et al., 1993) . Functional studies using a partial-loss-of-function approach revealed that ets-2 is necessary for the maturation of Xenopus oocytes (Chen et al., 1990) . Gain of function analysis of Xfli suggested an influence in cell adhesion.
Overexpression of Xfli affected head and erythroid differentiation (Remy et al., 1996) . Little is known about the role of the Ets subfamily (the PEA3 group) during embryogenesis. This group of Ets transcription factors comprises the three members PEA3, ERM and ER81. They share an acidic domain of high sequence similarity at the N-terminal end of the protein . The PEA3 group members are putative transcriptional activators which can interact with other proteins such as c-jun and the androgen receptor. Remodeling of the extracellular matrix is a possi- ble function . Expression analysis of the PEA3 group in the mouse suggests a role in epitheliomesenchymal interactions during organogenesis (ChotteauLelievre et al., 1997).
Here we report the isolation and characterization of the first Xenopus member of the PEA3 group, XER81. The XER81 gene is the homolog of the mouse and human genes ER81 as judged by sequence comparison (Brown and McKnight, 1992; Jeon et al., 1995; Monte et al., 1995) . The 477 amino acid putative translation product contains an ETS domain which is 100% identical to the one of the other ER81 genes.
Three transcripts (3, 4 and 6 kb), which are specific for XER81, were maternally expressed. Zygotic mRNAs, which gradually replace maternal mRNAs, are maintained until late tailbud stages (Fig. 2) . Embryo dissections and animal cap assays demonstrated that none of them, however, was germ layer or stage specific. The existence of three transcripts could be due to differential splicing as previously reported for other members of the Ets family (Leprince et al., 1988; Koizumi et al., 1990) . Only two transcripts (3.2 and 6.4 kb) were reported for the mouse ER81 (Chotteau-Lelievre et al., 1997) , however the function of the different ER81 messages during embryogenesis remains to be investigated.
The spatial distribution of XER81 mRNA during early embryogenesis was analyzed by whole-mount in situ hybridization. Transcripts appear in the animal cap and the marginal zone of gastrula stage embryos, later in the neural crest, the eyes, ear vesicles and pronephric duct. This pattern overlaps with other members of the Xenopus ETS family, X-ets-1, X-ets-2 and Xfli, which are also expressed in regions of the embryo that undergo important structural reorganization, accompanied by cell migration, such as the neural crest cells and the pronephric duct (Meyer et al., 1995; Meyer et al., 1997) .
The expression of XER81 in the marginal zone during gastrula stages implies a role for this gene in mesoderm specification. XER81 could be one of the zygotic determinants that participates in giving the marginal zone its mesodermal identity. As a transcription factor, XER81 could modulate the expression of mesoderm-specific genes but, as yet, no target genes of this ETS protein have been identified in Xenopus embryos. The temporal and spatial expression pattern of two transcription factors, Xbra and Xcad-2, which are involved in dorsoventral patterning of the mesoderm are not altered after overexpression of myc-tagged XER81 protein. One interpretation for the inability of XER81 to modulate Xcad-2 and Xbra expression is that these genes are either upstream or independent of XER81. A better understanding how Ets proteins regulate their targets and the availability of dominant negative mutants of XER81 which would enable us to perform partial loss-offunction experiments are needed to further characterize the function of XER81 in vivo.
Regulation of the XER81 gene
The mechanism that leads to the transcriptional activation of XER81 and the mode of action of the XER81 protein in the embryo is unknown. The acidic domain in the N-terminus of the PEA3 group, including XER81, is required for transactivation in vitro . For the repressing activity of Ets proteins such as ERF, a domain located in the carboxy terminus of the protein is necessary (Sgouras et al., 1995) . In order to activate and repress Ets family members, phosphorylation through MAP kinase is required for functional proteins (Wasylyk and Nordheim, 1997) . One subfamily of Ets proteins, the Elk group, forms ternary complexes with serum response factor (SRF) and is involved in the transcriptional activation of immediate early genes such as c-fos and egr-1 (Janknecht et al., 1993; Panitz et al., 1998) . This shows that Ets transcription factors are downstream components in the FGF/ MAPK signaling pathway. No ternary complex formation has been demonstrated yet for the PEA3 group proteins. It is also not known whether FGF signaling is involved in tran- 5) . Addition of the full-length FGF receptor rescues the inducing activity of FGF in the presence of XFD (lane 6). Fig. 7 . Expression of XER81myc in Xenopus embryos. (A) Embryos were injected with either 600 pg of CMTXER81 DNA or 2 ng of XER81myc mRNA and proteins were isolated at stage 10.5. SDS-PAGE was performed with one embryo equivalent from DNA injected or two equivalents from mRNA injected or not injected control embryos. Western blotting was done with the anti-myc antibody 9E10. XER81myc protein of the expected size of 71 kDa was detected. (B) Albino embryos were injected with 500 pg of XER81myc mRNA and whole-mount immunostaining was performed with the anti-myc antibody at stage 10.5. XER81myc protein was detected at the site of injection (B, a). Higher magnification of cleared embryos revealed a strong XER81 signal in the nuclei and weaker staining in the cytoplasm (B, b). (C) Embryos were injected with 2 ng of XER81 mRNA and whole-mount in situ hybridization was performed at stage 10.5 with antisense mRNA probes for Xbra and Xcad-2. Overexpression of XER81 did not change the expression pattern of Xbra (b) and Xcad-2 (d) compared to uninjected control embryos (a, c). Bar in B corresponds to 25 mm. scriptional activation of Ets genes but several lines of evidence indicate that the transcription of XER81 is influenced by FGF signaling. (1) Transcription of XER81 was induced in animal cap cells which were exposed to FGF. When these cells express a dominant negative version of the FGF receptor, the XER81 induction by FGF was blocked. The inhibiting effect of the dominant negative FGF receptor could be rescued by overexpression of the wild type FGF receptor (Fig. 6D, lane 6) . The vegetal region of the early embryo is devoid of FGF signaling, however overexpression of eFGF or eFGF plus the FGF receptor in vegetal explants stimulated the expression of XER81 as well as the panmesodermal marker Xbra. (2) The down regulation of XER81 transcription after blocking of the FGF signaling pathway was also observed in vivo. When dominant negative FGF receptor was expressed in the prospective mesoderm XER81 transcription was reduced at the sites of injection (Fig. 6B) . (3) The active domains of maternal bFGF protein and zygotic eFGF correlate well with the expression of XER81 in the embryo. bFGF is localized in the animal hemisphere of the blastula embryo and could account for the activation of XER81 in the animal pole region after mid blastula transition. At the onset of gastrulation, zygotic eFGF is enriched in the marginal zone concomitant with an elevated MAP kinase activity (LaBonne and Whitman, 1997) . The marginal zone shows elevated levels of XER81 transcription at this stage in development which can be suppressed by the dominant negative FGF receptor mutant. In later stages of embryonic development, eFGF and XER81 transcription is confined to the head region and the tailbud. The overlapping domains of eFGF and XER81 together with the finding that eFGF is sufficient to induce XER81 in vegetal caps argue for XER81 transcription being a marker for FGF activity in the developing embryo (Fig. 8) . Active FGF signaling in the blastula and early gastrula would then be confined to the animal pole and the marginal zone. Such a scenario, in which FGF activity was located animally and TGF-b activity vegetally, was proposed by Cornell et al. (1995) . In their model, the mesoderm develops in the embryo where these activities overlap, in the marginal zone. The analysis of XER81 transcription can therefore help to dissect TGF-b and FGF signaling in the embryo both spatially and temporally. The identification of elements within the XER81 promoter that are needed for the response to FGF would be one step towards the understanding of gene regulation through the FGF signaling cascade.
Experimental procedures
In situ screen
A plasmid cDNA library was generated with the Superscript Plasmid System for cDNA Synthesis and Plasmid Cloning (Gibco) according to the manufacturer's instructions. Total RNA was extracted from ventral halves of Xenopus gastrula stage 10.0-12, the poly(A)
+ mRNA was isolated with oligo(dT)-cellulose (type 77F, Pharmacia). Clones were randomly picked from the library and PCR was performed with the SP6 and T7 polymerase primers for the vector pSportI to obtain the inserts. DIG-RNA was synthesized with DIG labeling mix and SP6 RNA-polymerase (Boehringer) to obtain labeled antisense RNA. Whole-mount in situ hybridization was performed as described previously (Harland, 1991) using gastrula, neurula and tailbud stages. The proteinase K step was done 30 min for whole-mounts and 15 min for 100 mm thick vibratome sections. One of the isolated clones was pSER81, the partial clone of XER81, with a length of 2.8 kb and missing 300 bp from the 5′ end of the coding region. This clone was used for in situ hybridizations after linearizing with SalI, and DIG-RNA was synthesized with SP6 RNA-Polymerase (Boehringer).
To isolate a full-length XER81 cDNA a Xenopus stage 18 lambda ZAP library (Stratagene) was screened with a 600 bp radioactively labeled cDNA fragment from the 5′ end of Fig. 8 . Expression of XER81 and FGF signaling, a model. The expression of XER81 is high in the animal part of the blastula embryo where we also find high levels of FGF signaling (A). The TGF-b-like signal in the vegetal part from which FGF signaling is excluded seems not to be sufficient to induce XER81 expression there. Mesoderm is induced where TGF-b-like and FGF signals overlap in the marginal zone. At gastrula stages XER81 is expressed most strongly in this region whereas expression in the animal pole decreases. XER81 transcription could be indicative of active FGF signaling in the early Xenopus embryo. clone pSER81. One isolated clone of 3.8 bp length contained the full coding region of the gene.
Northern blot
Total RNA from embryos of different stages was extracted with TriStar (AGS) according to the manufacturer's instructions. Denaturation buffer was added to the RNA to a final concentration of 50% formamide, 6% formaldehyde and 1× MOPS. After denaturation at 75°C for 10 min, RNA equivalent to 1.5 embryos was loaded on a 1% agarose gel containing 0.75% formaldehyde. Electrophoresis was performed in buffer containing 0.75% formaldehyde and 1× MOPS for 4 h at 80 V. The gel was equilibrated in phosphate buffer (15 mM NaH 2 PO 4 , 6 mM Na 2 HPO 4 (pH 7.0)) for 0.5 h and the RNA was transferred to a Nylon membrane (GeneScreen, NEN) according to Sambrook et al. (1989) . The RNA was immobilized on the membrane by baking in a vacuum oven for 2 h at 80°C. Prehybridization was performed in hybridization solution (50 g dextrane sulfate, 166 ml NaP i (pH 7.0), 100 ml 50 mM EDTA and 375 ml H 2 O) at 65°C for 3 h. The cDNA of clone pSER81 was radioactively labeled (PrimeIt kit, Stratagene) and hybridized to the immobilized RNA at 65°C for at least 16 h. After washing 2 × 15 min in 2× SSPE/0.5% SDS, 2 × 15 min and 1 × 30 min in 0.2× SSPE/0.1% SDS at 68°C the membrane was exposed to an X-ray film overnight.
RT-PCR analysis
Total RNA from four whole embryos or ten animal or vegetal caps was extracted with TriStar (AGS) according to the manufacturer's instructions. Reverse transcription (RT) was performed using AMV reverse transcriptase (Amersham) at 50°C for 30 min. Whole embryo (1/17), animal cap (0.2), vegetal cap (0.5) equivalents were used in a 10 ml PCR reaction containing 1 mCi [ 32 P]dCTP, 1 × PCR reaction buffer, 0.2 mM dNTP, 0.1 mg/ml BSA, 0.125 units Taq-polymerase (Pharmacia) and 12.5 pmol of each primer. Sequences of the primers used for polymerase chain reaction (PCR) analysis: XER81: (5′-CTCATGATTCAGAA-GAACTCTTCC and 5′-TGGAATAGCTGTTATCAG-AGATGG), product length 426 bp; Xbra: (5′-CACAGTT-CATAGCAGTGACCG and 5′-TTCTGTGAGTGTACGG-ACTGG), product length 323 bp; EF-1a: (5′-CAG-ATTGGTGCTGGATATGC and 5′-ACTGCCTTGATGA-CTCCTAG), product length 268 bp. The PCR was performed with all three primer pairs in a single tube with an annealing temperature of 57°C, Xbra and EF-1a for 26 cycles, XER81 for 22 cycles.
The primers used for the specific XER81 probe for Northern blotting were: (5′-AATTCACGCGTCGACCCACGC-GTC and 5′-TGAGCCAGGAATTCCTCTTGCCTC), and resulted in a probe representing nt 340-949 of XER81 (Fig. 1). 
Animal and vegetal cap assays
Animal caps were dissected from stage 8.5 embryos in 1 × MBSH and were incubated at room temperature in 0.5 × MBSH containing 0.1 mg/ml BSA. Recombinant human bFGF (Gibco, BRL) was added at 500 ng/ml and recombinant human activin A (gift of J. Smith) at 8 units/ ml. The animal caps were allowed to develop until control embryos reached stage 11, at which time they were collected for RNA isolation. When XFD was injected in the 2-4-cell stage embryos the dissected animal caps were transferred to 0.1 × MBSH at stage 10.5 and incubated without growth factors until stage 15, then the RNA was isolated. Vegetal caps were dissected from stage 8.5 embryos and treated like animal caps.
Embryo injections
Xenopus laevis females were injected in the dorsal lymph sac with 300-500 units of human chorion gonadotropin (Serva) to induce ovulation. Eggs were stripped from ovulating females and fertilized with macerated testis. After 25 minutes the embryos were dejellied in 2% cysteine (Serva, pH 8.0) and maintained in 1 × MBSH (88 mM NaCl, 1 mM KCl, 2.4 mM Na HCO 3 , 0.82 mM MgSO 4 , 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl, 10 mM HEPES (pH 7.4), 10 mg/ml streptomycin, 10 mg/ml penicillin) at room temperature. At the 2-4-cell stage embryos were injected either four times in the animal cap or two times in the vegetal pole and transferred to 0.1 × MBSH 1 h after injection. Capped sense RNA for injections was prepared with the message machine kit (Ambion) according to the manufacturer's instructions. The following plasmids were used as templates for transcription of sense RNA: XeFGF: pSP64T, restriction with AccI and transcription with SP6-RNA-Polymerase (Isaacs et al., 1992) , 10 pg/embryo injected; pXFD: pSP64T, restriction with EcoRI and transcription with SP6-RNA-Polymerase (Amaya et al., 1991) , 100 pg/embryo injected; pXFRdelta3′: pSP64T, restriction with SacI and transcription with SP6-RNA-Polymerase (Amaya et al., 1991) , 50 pg/embryo injected; CMTXER81: pCS2 + MT, restriction with XhoI and transcription with SP6-RNA-polymerase; CSXER81: pCS2 + , restriction with XhoI and transcription with SP6-RNA-polymerase.
Immunostaining
For Western blots proteins were extracted from embryos by sonication in 7 ml homogenization buffer (20 mM Tris (pH 7.5), 1 mM EDTA, 1% Triton X-100, 2 mM DTT, 150 mg/ml PMSF, 2.8 mg/ml Aprotinin) per embryo. Yolk was precipitated by centrifugation for 2 min at 14 000 rev./min at 4°C. Lipids were removed from the supernatant by extraction with an equal volume of 1,1,2-trichlorotrifluoroethane and centrifugation as before. Extracts were immediately heated in sample buffer (Laemmli, 1970) to 95°C. SDS-PAGE (Laemmli, 1970) was performed using a 12% polyacrylamide gel. The proteins were transferred to a nitrocellulose membrane (Schleicher and Schüll) (Townbin et al., 1979) and immunostained with the monoclonal mouse anti myc antibody 9E10 (Evan et al., 1985) .
For whole-mount antibody staining albino embryos were fixed in MEMFA (4% formaldehyde, 0.1 M MOPS (pH 7.4), 2 mM EGTA, 1 mM MgSO 4 ) for 2 h and blocked in 20% normal goat serum (NGS, Sigma) in PBS for 1 h, followed by an overnight incubation with the anti myc antibody 9E10 (Evan et al., 1985) . The samples were washed for 6 h with several changes of PBS. Peroxidase-conjugated Rabbit anti mouse antibody was used as a secondary antibody (Dianova, 1:5000). Staining was performed using DAB (Pierce). Embryos were cleared using Murray's solution (benzylalcohol/benzylbenzoate 1:2).
